Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;20(1):270-271.
doi: 10.1111/jth.15578. Epub 2021 Nov 22.

Persistent endotheliopathy in the pathogenesis of long COVID syndrome - Reply to comment from von Meijenfeldt et al

Helen Fogarty  1   2 , Ellie Karampini  1 , Andrew S O'Donnell  3 , Soracha E Ward  1 , Jamie M O'Sullivan  1 , James S O'Donnell  1   2   4 ; Irish COVID-19 Vasculopathy Study (iCVS) investigators
Affiliations
Comment

Persistent endotheliopathy in the pathogenesis of long COVID syndrome - Reply to comment from von Meijenfeldt et al

Helen Fogarty et al. J Thromb Haemost. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

James S. O'Donnell has served on the speaker's bureau for Baxter, Bayer, Novo Nordisk, Sobi, Boehringer Ingelheim, Leo Pharma, Takeda, and Octapharma. He has also served on the advisory boards of Baxter, Sobi, Bayer, Octapharma CSL Behring, Daiichi Sankyo, Boehringer Ingelheim, Takeda, and Pfizer. He has also received research grant funding awards from 3M, Baxter, Bayer, Pfizer, Shire, Takeda, 3M, and Novo Nordisk. The remaining authors have no conflict of interests to declare.

Comment on

References

    1. von Meijenfeldt FA, Havervall S, Adelmeijer J, Thalin C, Lisman T. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. Comment from von Meijenfeldt et al. J Thromb Haemost. 2021. doi:10.1111/jth.15280 - DOI - PMC - PubMed
    1. Townsend L, Fogarty H, Dyer A, et al. Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19(4):1064‐1070. doi:10.1111/jth.15267 - DOI - PMC - PubMed
    1. von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Sustained prothrombotic changes in COVID‐19 patients 4 months after hospital discharge. Blood Adv. 2021;5:756‐759. doi:10.1182/bloodadvances.2020003968 - DOI - PMC - PubMed
    1. Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546‐2553. doi:10.1111/jth.15490 - DOI - PMC - PubMed
    1. Hulshof AM, Braeken DCW, Ghossein‐Doha C, et al. Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge. Res Pract Thromb Haemost. 2021;5:e12579. doi:10.1002/rth2.12579 - DOI - PMC - PubMed